CEO: Kevin C. Gorman

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.


Key numbers

Market Capitalization:10208619900
Shares Outstanding: 92094000
Float: 90689290.218
Next Earning Date:2020-02-06
TTm EPS: 0.2251
TTm Dividend Rate:
200 days moving average:88.05
50 days moving average: 96.51
One day percent Change: 0.32



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,